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Collateral nervous damages after cryoballoon pulmonary vein Isolation
Aurélie Guiot [Orateur], Arnaud Savoure, Bénédicte Godin, Frédéric Anselme
CHU Charles Nicolle, Cardiologie, Rouen, France
Background: Various types of complications have been reported after
atrial fibrillation (AF) ablation using radiofrequency energy but those have not
been well defined when using cryoballoon ablation technique. The objective
of this prospective study was to assess types, incidence and outcome of com-
plications after cryoballoon pulmonary venous isolation (PVI) for AF.
Methods: This prospective monocentric study included 66 FA consecutive
patients (39 males, age 57+/–11 years) who underwent cryoballoon PVI for
symptomatic paroxysmal AF. Phrenic nerve integrity was assessed by pacing
from the superior vena cava during isolation of the right PVs. Before dis-
charge, all patients were subjected to 24-hour Holter electrocardiograms,
echocardiography, and esophagogastroduodenoscopy (EGD). Cardiac MRI
was scheduled between 1 and 3 months post-procedure. At a mean follow up
of 3.7±1.7 months after ablation, patients underwent clinical review and
24 hour Holter electrocardiograms.
Results: The mean number of balloon cryoapplications was 10.0±2.1
per patient and 2.5±1.0 per vein. A 28 mm cryoballoon was used in
49 patients (74%) and a 23 mm cryoballoon in the 17 remaining patients
(26%). Nine patients experienced complications attributed to collateral
nervous damage (14%): Asymptomatic gastroparesis was observed in 6 pts
(9%), transient phrenic nerve palsy (PNP) in 5 (8%), and symptomatic
inappropriate sinus tachycardia requiring beta blocker treatment in 1 (1.5%).
Neither cryoballoon related-esophageal ulceration nor PV stenosis was
observed.
Conclusion: Gastroparesis, PNP and sinus tachycardia could be observed
in a significant number of cases after cryoballoon ablation of AF. These com-
plications are likely due to cryo-induced damages of nervous structures sur-
rounding the heart.
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Remote magnetic navigation in catheter ablation of persistent atrial
fibrillation
Mathieu Arnoult [Orateur], Decebal Gabriel Latcu, Philippe Ricard, Nadir
Saoudi
CH Princesse Grace, Monaco
Introduction: Efficacy of magnetic navigation for ablation of paroxysmal
atrial fibrillation (AF) has been shown. However data are sparse in patients
(pts) with persistent AF.
Aims: We report our experience using Magnetic Navigation System
(MNS) (Niobe, Stereotaxis) for catheter ablation of persistent AF.
Methods: Nineteen consecutive symptomatic pts (18 male, age 60,4±1,9 y)
with drug-resistant AF underwent ablation with an irrigated tip catheter, in
combination with a three dimensional electroanatomical mapping system
(Carto RMT). Ablation strategy consisted in wide area circumferential pulmo-
nary vein (PV) ablation with validation for electrical PV disconnection by a
circular mapping catheter, followed by complex fractionated atrial electro-
grams (CFAE) ablation, linear lesions and non PV foci ablation as required.
After discharge, pts were scheduled for repeated visits, ECGs and holter
recordings at 3 and 6 months (mth).
Results: AF history was 5,5 y and mean duration of the ongoing AF epi-
sode was 11 mth. Median left atrial (LA) size was 48,5 mm (28 cm2). All
pts underwent successful PV isolation, 74% linear lesions (LA roof line and/
or mitral isthmus line), 79% CFAE ablation and 28% non PV foci ablation.
Procedure duration was 215±50 min, fluoroscopy time 13±5 min (dose
849±534 mGy) and radiofrequency delivery duration 30±12 min. There was
no major complication. At 3 mth follow-up freedom from documented AF was
achievied in 35% of pts. After 1.8 procedures/pt and a median 6 mths follow-
up, 14 (73,7%) of 19 pts were in sinus rhythm.
Conclusions: Catheter ablation of persistent AF is effective and can be
safely performed using MNS. Efficacy is comparable to that reported with the
classic manual technique. Operator radioprotection and comfort are major
advantages in this type of lengthy procedure.
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Predictive value of sleep apnea syndrome on efficacity of atrial
fibrillation ablation (3A study)
Naïma Zarqane [Orateur] , Michel Ange Cellario, Decebal Gabriel Latcu,
Céline Dugourd, Philippe Ricard, Nadir Saoudi
CH Princesse Grace, Cardiologie, Monaco
Background: The association of atrial fibrillation (AF) and sleep apnea
syndrome (SAS) is well established. The aim of this prospective study was
to estimate the relation between presence of SAS and outcome of first AF
ablation.
Methods and results: 49 patients (Pts) with symptomatic drug resistant
AF (71% paroxysmal) were included prospectively. All underwent clinical
evaluation, Berlin Questionnaire (BQ), transthoracic echocardiogram, and
overnight polygraphic study (OPS) before pulmonary vein isolation (with
possible lines/defragmentation in persistent forms). SAS were classified
according to the apnea-hypopnea index (AHI, significant if >15). Follow-
up consisted of 3 months(M) visits and 24 h Holter at M6. Pts with AHI
>15 underwent a new OPS at M6. Any episode of AF or flutter >30 sec-
ondes was considered a recurrence. OPS showed SAS in 12 pts (25%,
6 obstructive). Seventeen pts had a high risk by BQ (42,8%). In SAS
group, age (65,7 vs 60,7, p=0.01) body mass index (27,3 vs 25,5, p=0.04)
and LA diameter (45 vs 41 mm, p=0.019) were higher whereas ejection
fraction was lower (49% vs 63%, p=0.001). At M6, 29% of the SAS group
are AF free versus 78% in the other group. With multivariate analysis,
SAS was the only independent predictor of ablation failure (OR=7.33).
Conclusion: SAS was a powerful independent predictor for first AF abla-
tion failure.
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Prevalence of atrial fibrillation in an elderly contemporary French
cohort: the three city study-COVADIS
Guillaume Fleury [Orateur] (1), Nabila Haddour (1), Christophe Tzourio (2),
Cohen Ariel (1)
(1) AP-HP, CHU Saint-Antoine, Paris, France – (2) AP-HP, CHU La
Pitié-Salpêtrière, Paris, France
Background: Atrial fibrillation (AF) is a major public health concern
worldwide. Prior studies have established that key risk factors for the development
of AF include, age, hypertension, coronary artery disease (CAD), heart failure,
Nervous complications after cryoballoon ablation of AF (%)
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and valvular heart disease. However, there have been few studies on the risk
for development of AF in an elderly cohort, taking into account ECG vari-
ables.
Aims: We aimed to evaluate the clinical and ECG predictors of preva-
lent AF in a large population-based prospective cohort study. The clinical
and ECG workups were realized at admission and after 4 years of follow-
up.
Methods: The study is part of the Three City Study (COVADIS), which
included subjects aged 65 years and above and not institutionalised. The prev-
alence of AF at baseline was assessed in 4234 patients.
Results: The overall prevalence was 2,33%. Based on multivariable
analyses, the HR was 2.08 [95% CI: 1.07-4.54], p=0.03) for male gender.
Age above 75 years was associated with an increase of AF prevalence (HR
1.92 [95% CI: 1.24-2.97], p=0.003) as well as history of stroke (HR=2.90
[95% CI: 1.15-6.56], p=0.02), history of AF (HR, 2.74 [95% CI: 1.12-
6.20], p=0.02). None of the other classical clinical risk factors was associ-
ated with AF prevalence. Q waves and ST segment depression on the base-
line ECG were associated with an increased prevalence of AF: HR, 2.70
[95% CI: 2.13-6.44], p<0.001) and HR, 12.6 [95% CI: 6.56-23.8],
p<0.001, respectively.
Conclusion: In a contemporary cohort of elderly subjects, ECG variables
suggesting CAD, history of previous AF, history of stroke, age and gender
were predictors of AF prevalence.
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Management of recent onset atrial fibrillation in the RHYTHM-AF
study: a survey of French cardioversion practice
Jean-Yves Le-Heuzey [Orateur] (1), Yves Cottin (2), Khalife Khalife (3),
Thierry Jammes (4), Hakima Hannachi (5)
(1) AP-HP, Hôpital Européen Georges Pompidou, Cardiologie et Rythmo-
logie, Paris, France – (2) CHU Bocage, Cardiologie, Dijon, France –
(3) Hôpital Notre Dame de Bon Secours, Cardiologie, Metz, France –
(4) CHr, Cardiologie, Bastia, France – (5) MSD-Chibret, Département
médical, Paris, France
Purpose: The prevalence of atrial fibrillation (AF) is increasing world-
wide, affecting 4.5 million people in the European Union, and up to 1 million
people in France. Yet, cardioversion practices (CV) are not well documented.
The RHYTHM-AF international observational study aimed to describe
regional patient populations and CV practices.
Methods: Consecutive adult candidates for CV with documented recent
AF were enrolled from hospitals in 10 countries. Information on French
patients was collected between September 2010 and April 2011 in 25 centers.
Descriptive statistics were used to document patient characteristics and CV
practices.
Results: Among the first 492 French enrolled patients, mean age was
69 years, 65% were male, 57% were hypertensive, 16% diabetic and 16%
presented with a history of chronic heart failure while a quarter (26%) showed
heart failure symptoms. Transthoracic and transesophageal echocardiography
were available in 70% and 30% of patients, respectively.
Over half (56%) of all patients underwent an attempt at CV; and the
majority of them (80%) underwent electrical CV. The remaining 20% under-
went pharmacological CV, most (81%) using amiodarone IV. At hospital dis-
charge, the median length of stay was 46 hours (IQR: 26-84) for electrical CV
and 203 hours (IQR: 91-409) for pharmacological CV. Also at discharge, 73%
of patients were in normal sinus rhythm, 92% were prescribed anticoagulation
drugs, and 63% anti-arrhythmic drugs. Adverse events occurred in 3% of
patients and in-hospital mortality was 0.6%.
Conclusions: In France, observations suggest that current cardiology
ward management of recent onset AF involves attempted CV in just over
half of patients considered for CV. Among those cardioverted, treatment is
oriented towards electrical CV, with a median length of in-hospital stay of
2 days. While electrical CV seems to be the preferred option of French
cardiologists, amiodarone IV is nonetheless their first pharmacological
treatment choice.
Table – Results
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Symptoms, functional status, and quality of life in patients with con-
trolled and uncontrolled atrial fibrillation. Data from the cross-sectio-
nal REALISE-AF registry
Philippe Gabriel Steg [Orateur] (1), Samir Alam (2), Chern-En Chiang (3),
Habib Gamra (4), Marnix Goethals (5), Hiroshi Inoue (6), Laura Krapf (1),
Thorsten Lewalter (7), Ihsen Merioua (8), Jan Murin (9), Lisa Naditch-Brule (8),
Piotr Ponikowski (10), Marten Rosenqvist (11), Jose Silva-Cardoso (12), Oleg
Zharinov (13), Sandrine Brette (14), Jim O'Neill (15)
(1) AP-HP, CHU Bichat-Claude-Bernard, Paris, France – (2) AUB, Bey-
routh, Liban – (3) National Yang Ming University, Taipei, Taïwan – (4)
Hôpital Universitaire Fattouma Bourguiba , Monastir, Tunisie – (5) H.-
Hartziekenhuis Roeselare-Menen, Roeselare, Belgique – (6) Second
Departmet of Internal Medicine, University of Toyama, Toyama, Japon –
(7) Academic Hospital University of Bonn, Bonn, Allemagne – (8) sanofi-
aventis, Paris 08, France – (9) Comenius University, Bratislava, Slova-
quie – (10) Université de Wroclaw, Wroclaw, Pologne – (11) Karolinska
Institute, Stockholm, Suède – (12) Porto Medical School, Hospital S. João,
Porto, Portugal – (13) National Medical Academy of Postgraduate Edu-
cation, Kiev, Ukraine – (14) Lincoln, Paris, France – (15) Connolly/Mater
Hospitals/RCSI, Dublin, Dublin, Ireland
Background: Both rate- and rhythm-control are accepted management
strategies for atrial fibrillation (AF). The frequency of success of either
strategy and the impact of control on symptomatic status of AF patients have
not been described,
Methods: RealiseAF was a multicentre, international, observational, cross-
sectional survey of patients with any AF history in the previous 12 months,
performed in 2009-10 by random sampling of cardiologists and internists. It
aimed to describe the characteristics, symptoms, quality of life (QoL), and
management patterns of AF patients, and determine the frequency of AF con-
trol (defined as sinus rhythm or AF with resting heart rate 80 beats per
minute [bpm]).
Findings Of 10546 patients enrolled, 10 523 were eligible for analysis and
9665 evaluable for AF control. AF was controlled in 59.0% of patients (sinus
rhythm 26.5%, AF 80 bpm 32.5%), and uncontrolled in 41.0%. Symptom
prevalence in the previous 7 days was lower in controlled than uncontrolled
AF (55.7% vs 68·4% respectively; p<0.001) and similar for patients in sinus
rhythm and patients in AF 80 bpm (54·8% vs 56.4%; p=0.23). On the day of
the visit, AF-related functional impairment (European Heart Rhythm Associa-
tion Class >1) was observed in 67.4% of controlled and 82.1% of uncontrolled
AF patients (p<0.001). QoL (measured using the EQ-5D tool) was better for
patients with controlled versus uncontrolled AF for all measures: visual analog
Total Cardioverted No CV
Total (N (%)) 492 
(100%)
277 (56%) 215 
(44%)
1st detected AF 169 
(36%)
92 (33%) 77 
(40%)
Paroxsymal AF 94 
(20%)
39 (14%) 55 
(28%)
Persistent AF 144 
(31%)
97 (35%) 47 
(24%)
CHADS2 score (mean, (SD)) 1.3 
(1.1)
1.4 (1.1) 1.1 
(1.0)
Mode of Cardioversion
Total PhCV ECV No CV
Total (N (%)) 492 
(100%)
55 
(11%)
226 
(46%)
215 
(44%)
LoS, hours (median (IQR)) 48 
(22-144)
203 
(91-409)
46
 (26-84)
62 
(4-134)
Time to CV, hours (median 
(IQR))
21 
(16-49)
24 
(5-74)
21
 (18-46)
–
